Comparison of the therapeutic effects of dexamethasone, metoclopramide, ketorolac, and chlorpromazine on clinical symptoms of patients with acute migraine headache
Phase 2
- Conditions
- acute migraine headache.Migraine with aura
- Registration Number
- IRCT201611239014N133
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
Acute migraine headache; severity of pain at least 4 based on Visual Analog Scale.
Exclusion criteria: Pregnancy; breastfeeding; hypertension; renal failure; heart disease; respiratory disease; liver failure; seizure; malignancy; infection or inflammation; peptic ulcer; neurological abnormalities; using immunosuppressive drugs; using ergotamine during last 8 hours; using sedative during last 4 hours.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of headache. Timepoint: before intervention and one and 24 hours after intervention. Method of measurement: using VAS.
- Secondary Outcome Measures
Name Time Method Adverse effect of the drugs. Timepoint: one and 24 hours after intervention. Method of measurement: through history taking.